- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 19/22 - Radicaux ptéridine
Détention brevets de la classe C07H 19/22
Brevets de cette classe: 25
Historique des publications depuis 10 ans
|
4
|
1
|
2
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Gilead Sciences, Inc. | 2070 |
3 |
| Pioneer Hi-Bred International, Inc. | 6720 |
2 |
| Epizyme, Inc. | 374 |
2 |
| Janssen Pharmaceuticals, Inc. | 441 |
1 |
| Amgen Inc. | 4158 |
1 |
| The Johns Hopkins University | 5739 |
1 |
| Northwestern University | 3442 |
1 |
| BioCryst Pharmaceuticals, Inc. | 169 |
1 |
| Biophore India Pharmaceuticals Pvt. Ltd. | 80 |
1 |
| Carnegie Mellon University | 1567 |
1 |
| Cornell Research Foundation, Inc. | 236 |
1 |
| Daiichi Sankyo Company, Limited | 1878 |
1 |
| Idenix Pharmaceuticals LLC | 61 |
1 |
| Karagen Pharmaceuticals | 2 |
1 |
| ScinoPharm Taiwan, Ltd. | 129 |
1 |
| Sloan-Kettering Institute for Cancer Research | 540 |
1 |
| Tagcyx Biotechnologies | 20 |
1 |
| University of Virginia Patent Foundation | 1598 |
1 |
| Tagcyx Biotechnologies Inc. | 16 |
1 |
| Scianda (Changshu) Pharmaceuticals, Ltd. | 4 |
1 |
| Autres propriétaires | 1 |